| [1] |
Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648.
|
| [2] |
Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors[J]. J Surg Oncol, 2013, 107(3): 230-236.
|
| [3] |
Choi YJ, Kim N. Gastric cancer and family history[J]. Korean J Intern Med, 2016, 31(6): 1042-1053.
|
| [4] |
Strong VE. Progress in gastric cancer[J]. Updates Surg, 2018, 70(2): 157-159.
|
| [5] |
Oliveira C, Pinheiro H, Figueiredo J, et al. Familial gastric cancer: genetic susceptibility, pathology, and implications for management[J]. Lancet Oncol, 2015, 16(2): e60-e70.
|
| [6] |
Polom K, Marrelli D, Voglino C, et al. Familial aggregation of gastric cancer with microsatellite instability[J]. Acta Chir Belg, 2018, 118(5): 287-293.
|
| [7] |
Hoshi H. Management of gastric adenocarcinoma for general surgeons[J]. Surg Clin North Am, 2020, 100(3): 523-534.
|
| [8] |
Coutzac C, Pernot S, Chaput N, et al. Immunotherapy in advanced gastric cancer, is it the future?[J]. Crit Rev Oncol Hematol, 2019, 133: 25-32.
|
| [9] |
Dassen AE, Dikken JL, Bosscha K, et al. Gastric cancer: decreasing incidence but stable survival in the Netherlands[J]. Acta Oncol, 2013, 53(1): 138-142.
|
| [10] |
Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development[J]. World J Gastroenterol, 2014, 20(18): 5461-5473.
|
| [11] |
Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma[J]. Gastric Cancer, 2015, 18(1): 23-32.
|